M. A. Maximova

M. A. Maximova

Auto-generated profile, based on publicly available information

M. A. Maximova

Gause Institute of New Antibiotics

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2026 in Antibiot Khimioter = Antibiotics and Chemotherapy
Verified
Journal Article
Closed access
ATA. S. Trenin
A. S. Trenin
ETE. A. Tsvigun
E. A. Tsvigun
MMM. A. Maximova
M. A. Maximova
MLM. I. Leonteva
M. I. Leonteva
AAAnastasia Avtonomova
Anastasia Avtonomova
LKLarissa Krasnopolskaya
Larissa Krasnopolskaya
Background . Cardiovascular and infectious diseases, especially those caused by pathogens resistant to existing drugs, remain the most important problem in modern medicine. The development of fundamentally new effective drugs is possible through the search for natural compounds. The use of new search methods and the involvement of new groups of organisms, including basidiomycetes, can significantly increase the efficiency of screening work and, ultimately, lead to the development of new, more effective drugs. The aim of the work was to identify sterol biosynthesis inhibitors (SBIs) among the metabolic products of higher fungi — Basidiomycetes . Materials and Methods. Basidiomycetes were grown using the submerged cultivation method. Ethyl acetate extracts from the culture broth and ethanol extracts from the mycelium of the producers were analyzed. The antibacterial and antifungal activity was assessed using the serial dilution method with determination of the minimum inhibitory concentration, as well as the agar diffusion assay. SBIs were detected utilizing a previously developed test system using the Halobacterium salinarum microbial model. Results. The study of Ganoderma lucidum, Kuehneromyces mutabilis, Flammulina velutipes, Pleurotus ostreatus , and Lentinula edodes strains revealed the ability of many strains to produce SBIs. The extracts of some L. edodes strains, as well as the extracts obtained from the mycelium of G. lucidum and K. mutabilis , were found to contain inhibitors of the early stages of sterol biosynthesis; their suppressive effect on the H. salinarum culture was removed by the addition of mevalonic acid. The antibiotic complexes of other strains apparently contained inhibitors of later (after the formation of mevalonate) stages of sterol biosynthesis. Some strains have also exhibited antibiotic activity, mainly against Gram-positive bacteria and fungi. Conclusion. Some of the studied strains demonstrated the ability to form inhibitors of the late stages of sterol biosynthesis. The ability to form inhibitors of early (before mevalonate formation) stages of sterol biosynthesis has been demonstrated in several L. edodes strains, as well as in the P. eryngii strain 10 used as a control.

5 September 2026 in Antibiot Khimioter = Antibiotics and Chemotherapy
Verified
Journal Article
Closed access
PDF file
ATA. S. Trenin
A. S. Trenin
ETE. A. Tsvigun
E. A. Tsvigun
MMM. A. Maximova
M. A. Maximova
MLM. I. Leonteva
M. I. Leonteva
LKLarissa Krasnopolskaya
Larissa Krasnopolskaya
ЛКЛ. М. Краснопольская
Л. М. Краснопольская
Background . Treatment of infectious, tumor, and cardiovascular diseases remains the most important task of modern medicine. The search for biologically active secondary metabolites allows us to detect natural compounds that can serve as the basis for the development of fundamentally new drugs. The use of original search methods and the involvement of new groups of organisms, including basidiomycetes, can significantly increase the efficiency of screening work and, ultimately, lead to the development of new, more effective drugs. The aim of the work was to reveal the ability of Basidiomycetes to produce sterol biosynthesis inhibitors (SBIs) and metabolites with antimicrobial properties. Material and methods . Basidiomycetes were grown using the submerged cultivation method. Biologically active compounds were obtained by extraction with ethyl acetate from the culture broth and with ethanol from the mycelium of the producers. The antibacterial and antifungal activity of the extracts with determination of the minimum inhibitory concentration was assessed using the serial dilution method in liquid media, as well as the agar diffusion assay. To detect SBIs, a test system with Halobacterium salinarum microbial culture, which possesses the mevalonate pathway of sterol biosynthesis, was used. Results . Basidiomycete strains belonging to the species C yclocybe cylindracea, Hericium erinaceus, Stropharia rugosoannulata and Hypsizygus ulmarius grown by submerged cultivation showed antibacterial and antifungal activity. In the microbial system of H. salinarum , the studied strains of C. cylindracea, S. rugosoannulata and H. ulmarius showed themselves as possible producers of SBIs. The strains C. cylindracea and H. ulmarius revealed the ability to form inhibitors of the early stages of sterol biosynthesis before the mevalonate formation. Conclusion. Among the 4 studied basidiomycete strains, 3 strains — C. cylindracea, S. rugosoannulata , and H. ulmarius — were identified as potential producers of SBIs. C. cylindracea and H. ulmarius strains demonstrated the ability to produce inhibitors of the early stages of sterol biosynthesis.